Drugs, devices and precision: the solution to AMR
This article was originally published in Clinica
Executive Summary
In November antibiotics are once again at the fore. Later this month Europe will be recognizing Antibiotic Awareness Day, and this week the UK will host the second BioInfect conference – which aims to bring together decision makers to mobilize global action on the crisis of antimicrobial drug resistance.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.